Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Opdivo approved via UK’s early drug access scheme

Opdivo approved via UK’s early drug access scheme Alimta (pemetrexed), and Roche's Tarceva (erlotinib) – all of which have seen positive NICE recommendations. .

NICE U-Turn on Boehringer oncology drug

NICE U-Turn on Boehringer oncology drug There are a number of NICE-approved medicines for NSCLC, including AstraZeneca's Iressa (gefitinib) and Roche's Tarceva (erlotinib), which are both targeted EGFR mutation positive treatments. .

Express Scripts pushes for pay-for-performance in cancer

Express Scripts pushes for pay-for-performance in cancer He gives the example of Roche and Astellas' Tarceva (erlotinib), which is less effective in pancreatic cancer than in lung cancer.

Survey reveals problems with lung cancer mutation testing

Survey reveals problems with lung cancer mutation testing Other drugs in the class approved to treat lung cancer include Iressa (gefitinib) from AstraZeneca (AZ) and Roche/OSI's Tarceva (erlotinib), with several more coming through the pipeline.

Stratified medicines face uptake challenges in the NHS

Stratified medicines face uptake challenges in the NHS Several stratified medicines for cancer have been launched in the UK, including Pfizer's Xalkori, Roche's Tarceva and AstraZeneca's Iressa - but they have tended to face difficulties when it

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics